AJP - Heart BIOPAC complete lab solutions
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 291: H3065-H3075, 2006. First published July 21, 2006; doi:10.1152/ajpheart.00353.2006
0363-6135/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/6/H3065    most recent
00353.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, Y.
Right arrow Articles by Anderson, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, Y.
Right arrow Articles by Anderson, M. E.

Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo

Yingbo Yang,1 Wei-Zhong Zhu,2 Mei-ling Joiner,3 Rong Zhang,1 Carmine V. Oddis,1 Yue Hou,1 Jinying Yang,3 Edward E. Price,4 Linda Gleaves,1 Mesut Eren,1 Gemin Ni,3 Douglas E. Vaughan,1,5 Rui-Ping Xiao,2 and Mark E. Anderson3,6

1Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee; 2Laboratory of Cardiovascular Science, National Institutes of Aging, National Institutes of Health, Baltimore, Maryland; 3Department of Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa; 4Department of Molecular Physiology and Biophysics, Vanderbilt University Medical Center; 5Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee; and 6Department of Physiology, Carver College of Medicine, University of Iowa, Iowa City, Iowa

Submitted 2 April 2006 ; accepted in final form 17 June 2006

Inhibition of the multifunctional Ca2+/calmodulin-dependent protein kinase II (CaMKII) or depletion of sarcoplasmic reticulum (SR) Ca2+ stores protects against apoptosis from excessive isoproterenol (Iso) stimulation in cultured ventricular myocytes, suggesting that CaMKII inhibition could be a novel approach to reducing cell death in conditions of increased adrenergic tone, such as myocardial infarction (MI), in vivo. We used mice with genetic myocardial CaMKII inhibition due to transgenic expression of a highly specific CaMKII inhibitory peptide (AC3-I) to test whether CaMKII was important for apoptosis in vivo. A second line of mice expressed a scrambled, inactive form of AC3-I (AC3-C). AC3-C and wild-type (WT) littermates were used as controls. AC3-I mice have reduced SR Ca2+ content and are resistant to Iso- and MI-induced apoptosis compared with AC3-C and WT mice. Phospholamban (PLN) is a target for modulation of SR Ca2+ content by CaMKII. PLN–/– mice have increased susceptibility to Iso-induced apoptosis. Verapamil pretreatment prevented Iso-induced apoptosis in PLN–/– mice, indicating the involvement of a Ca2+-dependent pathway. AC3-I and AC3-C mice were bred into a PLN–/– background. Loss of PLN increased and equalized SR Ca2+ content in AC3-I, AC3-C, and WT mice and abolished the resistance to apoptosis in AC3-I mice after MI. There was a trend (P = 0.07) for increased Iso-induced apoptosis in AC3-I mice lacking PLN compared with AC3-I mice with PLN. These findings indicate CaMKII is proapoptotic in vivo and suggest that regulation of SR Ca2+ content by PLN contributes to the antiapoptotic mechanism of CaMKII inhibition.

myocardial infarction; isoproterenol; programmed cell death; phospholamban



Address for reprint requests and other correspondence: M. E Anderson, Dept. of Medicine, Carver College of Medicine, Univ. of Iowa, Iowa City, IA 52242 (e-mail: mark-e-anderson{at}uiowa.edu)




This article has been cited by other articles:


Home page
PhysiologyHome page
L. F. Couchonnal and M. E. Anderson
The Role of Calmodulin Kinase II in Myocardial Physiology and Disease
Physiology, June 1, 2008; 23(3): 151 - 159.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. A. Werdich, E. A. Lima, I. Dzhura, M. V. Singh, J. Li, M. E. Anderson, and F. J. Baudenbacher
Differential effects of phospholamban and Ca2+/calmodulin-dependent kinase II on [Ca2+]i transients in cardiac myocytes at physiological stimulation frequencies
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2352 - H2362.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. Mao, S. Fukuoka, C. Iwai, J. Liu, V. K. Sharma, S.-S. Sheu, M. Fu, and C.-s. Liang
Cardiomyocyte apoptosis in autoimmune cardiomyopathy: mediated via endoplasmic reticulum stress and exaggerated by norepinephrine
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1636 - H1645.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
M. Kang, K. Y. Chung, and J. W. Walker
G-Protein Coupled Receptor Signaling in Myocardium: Not for the Faint of Heart
Physiology, June 1, 2007; 22(3): 174 - 184.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.